About The Medical Condition Drug Evaluation, FDA Phase II
Find the definition of the medical term Drug Evaluation, FDA Phase II. Drug Evaluation, FDA Phase II defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase II
| Drug Evaluation, FDA Phase II Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase II?
Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Acute Autoimmune Neuropathy ‐ An acute inflammatory autoimmune neuritis caused by T cell- mediated…
- Dicaine ‐ A potent local anesthetic of the ester type used for surface…
- Lymphoblastic Leukemia, CALLA-Positive ‐ Acute leukemia in which lymphocytes are positive for the common…
- Hypersensitivity, Respiratory ‐ A form of hypersensitivity affecting the respiratory tract. It…
- Utilitarianism ‐ A philosophically coherent set of propositions (for example,…
- VCAM-1 ‐ Cytokine-induced cell adhesion molecule present on activated…
- Statistical Studies ‐ The science and art of collecting, summarizing, and analyzing…
- Protein, Viral M ‐ Proteins associated with the inner surface of the lipid bilayer…
- Axolotls ‐ A genus of the Ambystomatidae family. The best known species…
- Hypersomnolence Disorders, Primary ‐ Disorders characterized by hypersomnolence during normal waking…